Cytokinetics, Incorporated (NASDAQ:CYTK) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Third Quarter 2023 Conference Call.
Source: insidermonkey.com
📰 Stuart Kupfer News
Stuart Kupfer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Stuart Kupfer. Real-time updates on events, politics, business and more.
Cytokinetics, Incorporated (NASDAQ:CYTK) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Second Quarter 2020 Conference Call.
Source: insidermonkey.com
Cytokinetics, Incorporated (NASDAQ:CYTK) Q4 2022 Earnings Call Transcript
Operator: Good afternoon and welcome ladies and gentlemen to Cytokinetics Fourth Quarter 2022 Conference Call.
Source: insidermonkey.com
Cytokinetics, Incorporated (CYTK) Q3 2022 Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ:NASDAQ:CYTK) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Diane Weiser - Senior Vice President, Corporate...
Source: seekingalpha.com
Cytokinetics, Incorporated (CYTK) CEO Robert Blum on Q1 2022 Results - Earnings Call Transcript
Cytokinetics, Incorporated (NASDAQ:NASDAQ:CYTK) Q1 2022 Earnings Conference Call May 4, 2022, 04:30 PM ET Company Participants Diane Weiser - SVP of Corporate Communications and IR Robert...
Source: seekingalpha.com
Experimental heart failure drug has little impact on exercise tolerance
Heart failure patients taking the investigational drug omecamtiv mecarbil, which has been previously shown to improve long-term outcomes, see little impact on their ability to exercise compared to a placebo, according to a study supported by the Duke Clinical Research Institute.
Source: news-medical.net
Investigational Drug for Heart Failure has Little Impact on Exercise Tolerance
Heart failure patients taking the investigational drug omecamtiv mecarbil, which has been previously shown to improve long-term outcomes, see little impact on t
Source: newswise.com
Cytokinetics, Incorporated (CYTK) Q3 2021 Earnings Call Transcript
CYTK earnings call for the period ending September 30, 2021.
Source: fool.com
Cytokinetics Inc (CYTK) Q1 2021 Earnings Call Transcript
Operator Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics First Quarter 2021 Conference Call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode. At the companys request, we will open the call for questions-and-answers after the presentation. I will now like to turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Communications and Investor Relations. Please go ahead. Dian...
Source: fool.com